Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Acadia Pharmaceuticals buy Mizuho

Acadia Pharmaceuticals
Start price
€20.85
23.02.26 / 50%
Target price
€29.59
23.02.27
Performance (%)
18.03%
Price
€24.87
20.08.26
Summary
This prediction is currently active. The prediction currently has a performance of 18.03%. This prediction currently runs until 23.02.27. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Acadia Pharmaceuticals 1.015% 1.015%
iShares Core DAX® -1.586% 5.028%
iShares Nasdaq 100 -4.148% -0.125%
iShares Nikkei 225® -6.302% 0.528%
iShares S&P 500 -3.225% 0.470%

Comments by Mizuho for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 18.03%
Target price 29.589
Change
Ends at 23.02.27

ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $35.00 price target on the stock, up previously from $29.00.
Ratings data for ACAD provided by MarketBeat

Mizuho 
0
Report Share
23.02.26

Stopped prediction by Mizuho for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€21.60
28.02.24
€36.02
28.02.25
-19.75%
01.03.25

Mizuho 
28.02.24 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€28.40
29.12.23
€36.19
29.12.24
-42.54%
30.12.24

Mizuho 
29.12.23 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€22.40
06.11.23
€32.59
06.11.24
-31.70%
07.11.24

Mizuho 
06.11.23 50%